PharmaDiversityJobBoard-Diversity Job Board connecting diversity & minority job seekers with Pharmaceutical jobs. AmerisourceBergen jobs (ABC)
  Home  |  Job Seekers  |  Employers  |  FAQ  |  Contact Us    You're not logged in!
  Login  |  Job Search  |  Job Seeker Register  |  Employer Register  |  Translate:

Roche Jobs

 
Click links to read Current News for this Featured Employer    Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's Actemra for Rheumatoid Arthritis However, Most Surveyed MCOs Won't Give Actemra More Favorable Reimbursement Than its Competitors, According to a New Report from Decision Resources | Value of Text Verification Tool (TVT) Strongly Confirmed at RAPS in Philadelphia | Appeals Court Affirms Patent Infringement Rulings Against Roche's peg-EPO Product | Two New Studies Report Increased Survival Rates in Tamiflu(R)-Treated Patients with Avian Flu (H5N1) and Severe Seasonal Flu Results of Two New Observational Studies Presented Today at the Interscience Congress on Antimicrobial Agents & Chemotherapy (ICAAC) | PTC Therapeutics Announces Drug Discovery Collaboration With Roche - Utilizing GEMS technology to address novel or intractable targets - | FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants - Plus new oral solution offers dosing flexibility for pediatric patients - | Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C - Study will further define the safety and efficacy profile -- Parallel Phase 1 trial will assess ritonavir-boosted dosing -- INFORM-1 study with polymerase inhibitor RG7128 ongoing - | Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product | McCallan and Excerpta Medica Launch MED SELECT Program at HCEA | Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier | Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer | Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients | moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico | Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes | Codexis R&D Productivity Panels Also Used By Roche | Roche Women Honored as 2009 TWIN Awardees | Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C | Roche Madison Moves to New Facility | Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment | BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services | Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU | Roche Completes Tender Offer for Genentech | BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer | Roche Announces Significant Price Reduction of Two ACCU-CHEK(R) Glucose Monitoring Kits to Help Customers With Diabetes During These Difficult Economic Times | Nektar Announces Retirement of Irwin Lerner from Board of Directors | VNUS Medical Technologies to Report Fourth-Quarter 2008 Results and Webcast Teleconference on February 10 | New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer | PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine | Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc. | Roche Offers Fun Experience with ACCU-CHEK(R) Aviva Through New Rock My Meter Website | FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C | VIA Pharmaceuticals Licenses Drug Candidates from Roche to Expand Cardiovascular Pipeline to Include Metabolic Disease | Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908 | Rochester Medical Introduces MAGIC.: The Next Generation of Intermittent Catheters | Enigma Diagnostics Announces a Signed Term Sheet for Patent Licenses with Roche Molecular Systems, Inc. | Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test | Improved Testing for Hepatitis B Virus From Roche | Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target | Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful | Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals | Roche Holds Sixth Annual Children?s Walk in Nutley | Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C | Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales | Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform | CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans | New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients | New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients | ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting | Real-Life Solutions for Women Working Through Cancer | Real-Life Solutions for Women Working Through Cancer | Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908 | Roche Announces Tamiflu(R) Antiviral Flu Medication in Ample Supply for 2008-2009 Flu Season | CEO Addresses St. Louis Business Leaders About Developing Pandemic and Business Continuity Plans | FDA Issues Complete Response Letter to Roche for ACTEMRA(R) (tocilizumab) Biologics License Application | Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program | InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche |
 
  
Items 1-0/0 displayed. [1-50]
SaveDateJob TitleCity CountryStateCompany NamePay
Nov 20 Associate Director, CMC Regulatory  Cambridge MA  Indeed
Nov 20 Sr. Manager, Clinical Operations  Cambridge MA  Indeed
Nov 20 Senior Manager, Data Management  Cambridge MA  Indeed
Nov 20 Scientist, Sr - 10194C - 0000  Dorado PR  Indeed
Nov 20 Pharmacist  Reno NV  Indeed
Nov 20 Bioanalytical Chemist (Discovery)  Princeton NJ  Indeed
Nov 20 Head of Intellectual Property (Generic Pharmaceuticals)  Miami FL  Indeed
Nov 20 Corporate Training Sales Pharmaceuticals NYQQT  Forest Hills NY  Indeed
Nov 20 Dir. of Marketing - Generic Pharmaceuticals  St. Louis MO  Indeed
Nov 20 Director, Business Development - Must have CNS, CRO exp  Hamilton NJ  Indeed
Nov 20 Accounting Manager - Public Pharmaceutical  Cambridge MA  Indeed
Nov 20 Sales Representative Pharmaceutical Colors - geh-SalesRepPharmaColors  Philadelphia PA  Indeed
Nov 20 Pharmaceutical Sales Rep  Philadelphia PA  Indeed
Nov 20 Pharmacy Director - SMK376  Columbus OH  Indeed
Nov 20 Pharmaceutical Project Manager  Philadelphia PA  Indeed
Nov 20 Tech Sales Pharmaceutical Manu - 121704296  Chicago IL  Indeed
Nov 20 COO (Pharmaceutical / Biotech experience)  Miami FL  Indeed
Nov 20 Pharmaceutical Copy Superhero  New York NY  Indeed
Nov 20 Sr. Product Marketing Manager - Pharmaceutical Packaging  Raleigh NC  Indeed
Nov 20 Director, Employee Communications / Executive  Chicago IL  Indeed
Nov 20 Pharmaceutical Company: Director, Marketing Sciences  New York NY  Indeed
Nov 20 Pharmaceutical Associate Brand Director - EPS -ABD  Raleigh NC  Indeed
Nov 20 Production Manager - Pharmaceutical Packaging  Albany NY  Indeed
Nov 20 Pharmacy Operations Manager 1674JL  Baltimore MD  Indeed
Nov 20 IT Outsourcing Sales to Pharma & Medical Device Cos.  New York NY  Indeed
Nov 20 Senior Counsel - Pharmaceutical Marketing & Sales Promotions  New York NY  Indeed
Nov 20 District Specialty Business Manager  Dallas TX  Indeed
Nov 20 National Sales Director  Fort Worth TX  Indeed
Nov 20 Oncology Sales Rep  Fort Lauderdale FL  Indeed
Nov 20 Dental Sales Manager  Baltimore MD  Indeed
Nov 20 Primary Care Clinical Sales Consultant  Denver CO  Indeed
Nov 20 Sales Manager Polymers & Resins - 20093250b  Chicago IL  Indeed
Nov 20 Hospital Key Account Manager  Chicago IL  Indeed
Nov 20 Global Account Executive  Indianapolis IN  Indeed
Nov 20 Clinical Sales Representative - 1393  New Orleans LA  Indeed
Nov 20 HVAC Sales Executive  Baltimore MD  Indeed
Nov 20 Director, Business Development and Strategic Alliances  Miami FL  Indeed
Nov 20 Method Development Scientist  Cortland NY  Indeed
Nov 20 Bio Pharma / Regulatory Compliance Management Consultants - J0121  New York NY  Indeed
Nov 20 Associate Director for Oncology Marketing Research  Stamford CT  Indeed
Nov 20 SVP / EVP - Client Services - SEVPCS  Philadelphia PA  Indeed
Nov 20 Medical Director  Chicago IL  Indeed
Nov 20 Associate Director of Regulatory Affairs - Pharma  Houston TX  Indeed
Nov 20 Medical Director, Pharmacovigilance  Boston MA  Indeed
Nov 20 Medical Science Liaison - EPS -MSL  Indianapolis IN  Indeed
Nov 20 Marketing Director  Greensboro NC  Indeed
Nov 20 Associate Director, Analytical Development  Boston MA  Indeed
Nov 20 Sr Director, Global Marketing Initiatives & Planning - OTC Therapeutics  Madison NJ  Indeed
Nov 20 QA Director - Medical Devices BHJOB1778_215  Raleigh NC  Indeed
Nov 20 Assistant Director of Branding  Dallas TX  Indeed
jobs by Indeed job search